• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含利福平的异烟肼-明胶结合微球用于治疗结核病。

Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.

机构信息

Department Scienze della Vita e dell'Ambiente, Sezione Scienze del Farmaco, Cagliari, Italy.

出版信息

J Pharm Pharmacol. 2013 Sep;65(9):1302-11. doi: 10.1111/jphp.12094. Epub 2013 Jul 5.

DOI:10.1111/jphp.12094
PMID:23927468
Abstract

OBJECTIVES

In this work, a new polymeric microparticle system based on gelatin covalently bound to isoniazid (ISN) and containing rifampicin (RFP) was prepared by spray-drying technique. Microparticle aptitude to nebulisation and their capability of interacting with A549, alveolar basal epithelial cells, were evaluated in vitro.

METHODS

Microparticles were obtained by spray drying, and their morphology, size, zeta potential, thermotropic behaviour and nebulisation ability were evaluated.

KEY FINDINGS

Microparticles were positively charged with a mean size of 4.88 ± 0.3 μm. Microspheres were able to incorporate both RFP and ISN: encapsulation efficiency was 51 ± 6% and 22 ± 1%, respectively. X-ray diffraction study showed a new extensive and flattened diffraction peak providing evidence that the drugs were dispersed into the microparticles. Differential scanning calorimetry analysis confirmed effective interactions between gelatin and drug molecules by the presence of new transition peaks. Fifty-nine per cent of used microparticles were aerosolised. In-vitro toxicity studies on A549 alveolar basal epithelial cells showed that microparticles decreased cytotoxicity in comparison with the RFP solution. Laser scanning confocal microscopy observation confirmed that fluorescent probes delivered by microparticles are efficiently internalised in A549 cells.

CONCLUSIONS

Overall, microparticles based on gelatin covalently bound to ISN and containing RFP showed a promising behaviour for pulmonary drug delivery.

摘要

目的

本研究采用喷雾干燥技术,制备了一种新型的基于共价结合异烟肼(ISN)的明胶聚合物微球系统,并载有利福平(RFP)。评估了微球的雾化适性及其与肺泡基底上皮细胞(A549)相互作用的能力。

方法

通过喷雾干燥获得微球,并对其形态、粒径、Zeta 电位、热行为和雾化能力进行了评估。

主要发现

微球带正电荷,平均粒径为 4.88±0.3μm。微球能够同时包封 RFP 和 ISN:包封效率分别为 51±6%和 22±1%。X 射线衍射研究表明,存在新的广泛且平坦的衍射峰,证明药物已分散在微球中。差示扫描量热法分析证实了明胶与药物分子之间存在新的转变峰,从而实现了有效相互作用。59%的使用微球被雾化。A549 肺泡基底上皮细胞的体外毒性研究表明,与 RFP 溶液相比,微球降低了细胞毒性。激光扫描共聚焦显微镜观察证实,荧光探针通过微球被有效地内化到 A549 细胞中。

结论

总的来说,基于共价结合异烟肼(ISN)的明胶微球并载有利福平(RFP)显示出了用于肺部药物传递的有前景的行为。

相似文献

1
Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.含利福平的异烟肼-明胶结合微球用于治疗结核病。
J Pharm Pharmacol. 2013 Sep;65(9):1302-11. doi: 10.1111/jphp.12094. Epub 2013 Jul 5.
2
One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.使用四流体喷嘴喷雾干燥器一步制备含利福平/聚乳酸-羟基乙酸共聚物纳米颗粒的甘露醇微球用于肺结核吸入治疗
J Control Release. 2009 Apr 2;135(1):19-24. doi: 10.1016/j.jconrel.2008.11.027. Epub 2008 Dec 7.
3
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.用于实验性结核病的基于聚(DL-丙交酯-共-乙交酯)纳米颗粒的可吸入持续给药系统
J Antimicrob Chemother. 2003 Dec;52(6):981-6. doi: 10.1093/jac/dkg477. Epub 2003 Nov 12.
4
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.吸入性固体脂质微粒靶向肺泡巨噬细胞治疗结核病
Int J Pharm. 2014 Feb 28;462(1-2):74-82. doi: 10.1016/j.ijpharm.2013.12.034. Epub 2013 Dec 25.
5
Respirable rifampicin-based microspheres containing isoniazid for tuberculosis treatment.含异烟肼的可吸入利福平微球用于结核病治疗。
J Biomed Mater Res A. 2012 Feb;100(2):536-42. doi: 10.1002/jbm.a.33302. Epub 2011 Dec 8.
6
Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.含有药物组合的可吸入微粒,用于靶向肺泡巨噬细胞以治疗肺结核。
Pharm Res. 2001 Oct;18(10):1405-10. doi: 10.1023/a:1012296604685.
7
Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.基于藻酸盐的结核病口服给药系统:药代动力学与治疗效果
J Antimicrob Chemother. 2003 Apr;51(4):931-8. doi: 10.1093/jac/dkg165. Epub 2003 Mar 13.
8
Inhalable microparticles containing large payload of anti-tuberculosis drugs.含有大量抗结核药物的可吸入微粒。
Eur J Pharm Sci. 2007 Oct;32(2):140-50. doi: 10.1016/j.ejps.2007.06.006. Epub 2007 Jul 4.
9
Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.喷雾干燥颗粒作为抗结核药物的肺部给药系统:设计、优化、体外和体内评价
Pharm Dev Technol. 2016 Dec;21(8):951-960. doi: 10.3109/10837450.2015.1081613. Epub 2015 Aug 31.
10
Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.基于壳聚糖微粒的利福平与利福布汀干粉吸入制剂的研发与评价
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):179-95. doi: 10.1089/jamp.2014.1187. Epub 2015 Sep 25.

引用本文的文献

1
A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation.吸入用利福平制剂及临床前研究综述及其临床转化。
Drug Deliv Transl Res. 2023 May;13(5):1246-1271. doi: 10.1007/s13346-022-01238-y. Epub 2022 Sep 21.
2
Formulation and In Vitro Efficacy Assessment of Extract Loading Hyalurosomes Enriched with Tween 80 and Glycerol.富含吐温80和甘油的提取物负载透明质体的制剂及其体外功效评估
Nanomaterials (Basel). 2022 Mar 26;12(7):1096. doi: 10.3390/nano12071096.
3
Mouthwash Formulation Co-Delivering Quercetin and Mint Oil in Liposomes Improved with Glycol and Ethanol and Tailored for Protecting and Tackling Oral Cavity.
含槲皮素和薄荷油的漱口水制剂,采用脂质体共递送,通过乙二醇和乙醇改良,专为保护和应对口腔而定制。
Antioxidants (Basel). 2022 Feb 11;11(2):367. doi: 10.3390/antiox11020367.
4
Nanoparticles for antiparasitic drug delivery.纳米颗粒用于抗寄生虫药物递送。
Drug Deliv. 2019 Dec;26(1):1206-1221. doi: 10.1080/10717544.2019.1692968.
5
Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery.用于单核细胞靶向递送的pH敏感型异烟肼菊粉缀合物的合成与表征
Pharmaceutics. 2019 Oct 28;11(11):555. doi: 10.3390/pharmaceutics11110555.
6
Polymeric nanobiotics as a novel treatment for mycobacterial infections.聚合物纳米生物制剂作为一种新型的抗分枝杆菌感染的治疗方法。
J Control Release. 2019 Nov 28;314:116-124. doi: 10.1016/j.jconrel.2019.10.009. Epub 2019 Oct 21.
7
Glucosamine/L-lactide copolymers as potential carriers for the development of a sustained rifampicin release system using as a tuberculosis model.以结核为模型,研究氨基葡萄糖/L-丙交酯共聚物作为开发利福平缓释系统的潜在载体。
Heliyon. 2019 Apr 28;5(4):e01539. doi: 10.1016/j.heliyon.2019.e01539. eCollection 2019 Apr.
8
Cyto-genotoxicity Assessment of Potential Anti-tubercular Drug Candidate Molecule-trans-cyclohexane-1, 4-diamine Derivative-9u in Human Lung Epithelial Cells A549.潜在抗结核药物候选分子反式环己烷-1,4-二胺衍生物-9u对人肺上皮细胞A549的细胞遗传毒性评估
Toxicol Int. 2014 Jan;21(1):69-77. doi: 10.4103/0971-6580.128800.
9
Advances in device and formulation technologies for pulmonary drug delivery.肺部药物递送的装置与制剂技术进展
AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12.